These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 7527834

  • 1. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
    Montaner LJ, Griffin P, Gordon S.
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G, Montaner LJ, Gordon S.
    J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
    [Abstract] [Full Text] [Related]

  • 3. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages.
    Kootstra NA, van 't Wout A, Huisman HG, Miedema F, Schuitemaker H.
    J Virol; 1994 Nov; 68(11):6967-75. PubMed ID: 7933078
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression.
    Naif HM, Chang J, Ho-Shon M, Li S, Cunningham AL.
    AIDS Res Hum Retroviruses; 1996 Sep 01; 12(13):1237-45. PubMed ID: 8870845
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.
    Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S.
    J Exp Med; 1993 Aug 01; 178(2):743-7. PubMed ID: 8101865
    [Abstract] [Full Text] [Related]

  • 6. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation.
    Chang J, Naif HM, Li S, Jozwiak R, Ho-Shon M, Cunningham AL.
    AIDS Res Hum Retroviruses; 1996 Sep 01; 12(13):1227-35. PubMed ID: 8870844
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis.
    Wang Y, Rice AP.
    Virology; 2006 Sep 01; 352(2):485-92. PubMed ID: 16781761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity.
    Montaner LJ, Bailer RT, Gordon S.
    J Leukoc Biol; 1997 Jul 01; 62(1):126-32. PubMed ID: 9226003
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):321-31. PubMed ID: 9833740
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR.
    Mol Med; 1995 Sep 01; 1(6):667-77. PubMed ID: 8529133
    [Abstract] [Full Text] [Related]

  • 14. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
    Wang J, Crawford K, Yuan M, Wang H, Gorry PR, Gabuzda D.
    J Infect Dis; 2002 Apr 01; 185(7):885-97. PubMed ID: 11920312
    [Abstract] [Full Text] [Related]

  • 15. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778.
    Le Naour R, Clayette P, Henin Y, Mabondzo A, Raoul H, Bousseau A, Dormont D.
    J Gen Virol; 1994 Jun 01; 75 ( Pt 6)():1379-88. PubMed ID: 7515938
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
    Schafer EA, Venkatachari NJ, Ayyavoo V.
    Antiviral Res; 2006 Dec 01; 72(3):224-32. PubMed ID: 16889838
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.
    Yang JY, Schwartz A, Henderson EE.
    AIDS Res Hum Retroviruses; 1993 Aug 01; 9(8):747-54. PubMed ID: 7692906
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells.
    Akridge RE, Reed SG.
    J Infect Dis; 1996 Mar 01; 173(3):559-64. PubMed ID: 8627017
    [Abstract] [Full Text] [Related]

  • 20. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages.
    Akridge RE, Oyafuso LK, Reed SG.
    J Immunol; 1994 Dec 15; 153(12):5782-9. PubMed ID: 7527449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.